UMIN ID: C000000158
Registered date:01/04/2006
Mizoribin for primary nephrotic syndrome in children(JSRDC09)
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Steroid-sensitive nephrotic syndrome |
| Date of first enrollment | 2006/03/01 |
| Target sample size | 50 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | mizoribine+prednisolone |
Outcome(s)
| Primary Outcome | Relapse-free proportion |
|---|---|
| Secondary Outcome | Relapse-free time Freaquently relapse rate Steroid dependency rate Relapse rate Proportion f adverse events |
Key inclusion & exclusion criteria
| Age minimum | 1years-old |
|---|---|
| Age maximum | 10years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1.History of relapse. 2.Medical history of allergy or hypersensitivity reactions to mizoribine. 3.Poorly controlled hypertension. 4.Chronic renal dysfunction. 5.Active infectious disease. 6.Severe liver disfunction. 7.Hypocomplementemia 8.Pregnancy. 9.Judged inappropriate for this study by the physicians. |
Related Information
| Primary Sponsor | Japanese Study Group of Renal Disease in Children(JSRDC) |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The Kidney Foundation,Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| Affiliation | Japanese Study Group of Renal Disease in Children(JSRDC) Department of Pediatrics,Wakayama Medical University |
| scientific contact | |
| Name | Norishige Yosikawa |
| Address | 811-1 Kimiidera Wakayama City Wakayama Japan |
| Telephone | |
| Affiliation | Wakayama Medical University Department of Pediatrics |